Novartis' spending on research and development by segment 2017-2019

This statistic shows the expenditure on research and development of pharmaceutical company Novartis from 2017 to 2019, by business segment. In 2016 and 2017, in both years, the company spent around 7.6 billion U.S. dollars for research and development in the Innovative Medicines division.

Novartis AG's spending on research and development by segment from 2017 to 2019

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

January 2020

Region

Worldwide

Survey time period

2017 to 2019

Supplementary notes

All figures are rounded.
* During 2019, eye care division Alcon was spun off and became an own company. Thus, Alcon's R&D expenses are not included.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Novartis"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.